Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Quality of life and adherence to TKIs among pediatric, adolescent, and young adult CML patients: A systematic review of (Werk RS et al. Pediatric Blood Cancer, June 2025)

Quality of life and adherence to tyrosine kinase inhibitors among pediatric, adolescent, and young adult chronic myeloid leukemia patients: 
A systematic Review
Werk RS et al. Pediatr Blood Cancer, June 2025 – open access publication

 

 

 

 

Survival of European children, adolescents, and young adults diagnosed with haematological malignancies in the period 2000 - 2013: Results from EUROCARE-6, a population based study (Trama A et al. Eur J Cancer, June 2025)

Survival of European children, adolescents, and young adults diagnosed with haematological malignancies in the period 2000 – 2013: Results from EUROCARE-6, a population based study
Trama A et al. Eur J Cancer, June 2025 – open access publication

 

 

 

 

Allogeneic hematopoietic stem cell transplantation in pediatric and young patients with chronic myeloid leukemia in tyrosine kinase inhibitor era: A study of the Korean Blood an Marrow Transplantation Registry (Ju HY et al. Cancer Res Treat, May 2025)

Allogeneic hematopoietic stem cell transplantation in pediatric and young adult patients with chronic myeloid leukemia in tyrosine kinase inhibitor era: A study of the Korean Blood and Marrow Transplantation Registry
Ju HY et al. Cancer Res Treat, May 2025 (epub ahead of print) – open access publication

 

 

 

 

Genomic variant profiling in blast-phase paediatric chronic myeloid leukemia: Predisposing and driving alterations (Behrens YL et al. Br J Haematol, May 2025)

Genomic variant profiling in blast-phase paediatric chronic myeloid leukemia: Predisposing and driving alterations
Behrens YL et al. Br J Haematol, May 2025 (epub ahead of print)
– open access publication

 

 

 

 

NAMPT-mediated deacytylation of HCLS1 protein promoted clonogenic growth of pediatric CML cells (Samareh B et al. Exp Hematol, May 2025)

NAMPT-mediated deacetylation of HCLS1 protein promoted clonogenic growth of pediatric CML cells
Samareh B et al. Exp Hematol, May 2025 (epub ahead of print)

 

 

 

 

  1. Cases of patients treated in countries with limited resources and discussed by experts of the iCMLf - Case No 2: TFR after 9 years of imatinib treatment without prior achievement of sustained DMR (Michalowski MB et al. Case Reports in Oncological Medicine
  2. Management of children and adolescents with chronic myeloid leukemia in chronic-phase: International pediatric CML expert panel recommendations (Millot F et al. Leukemia, March 2025)
  3. Therapeutic drug monitoring of imatinib in pediatric chronic myeloid leukemia. Data from a real-world setting (Suttorp M et al. Br J Haematol, March 2025)
  4. Favourable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era (Yoshikawa T et al. Int J Hematol, March 2025)